| Ms Kristin L Hanson, MD | |
|
4100 S Lindsay Rd, Ste 130, Gilbert, AZ 85297-1508 | |
| (480) 782-9531 | |
| (480) 782-9530 |
| Full Name | Ms Kristin L Hanson |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 33 Years |
| Location | 4100 S Lindsay Rd, Gilbert, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659379378 | NPI | - | NPPES |
| 168460-01 | Medicaid | AZ | |
| A00150187 | Other | AZ | DRIVERS LICENSE |
| 21926 | Other | AZ | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 21926 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
| Dignity Health Arizona General Hospital | Mesa, AZ | Hospital |
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Huhu Kam Memorial Hospital | Sacaton, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pioneer Hospitalists, Pllc | 0941290290 | 51 |
News Archive
New research reveals a Medicaid payment model in Oregon leads to fewer traditional primary care services for patients, with the decrease focused entirely on imaging.
Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.
Transitioning from a hospital visit can be challenge for many patients, but the homeless face particular difficulties as they move to a shelter, or even back to the streets. Researchers in this study surveyed 98 homeless individuals in New Haven, Conn., as well as interviewed them about their experiences leaving the hospital. More than half said that their providers did not address housing or transportation, and 11 percent reported living on the streets on the night of their discharge. The authors recommend "improved assessment of housing status, communication between hospital and shelter providers, and arrangement of safe transportation" for homeless individuals.
Instrumentation Laboratory (IL) today announced the release of the new HemosIL HIT-Ab(PF4-H) assay as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Delivering results in minutes, the HemosIL HIT-Ab(PF4-H) assay detects total immunoglobulin against Platelet Factor 4-Heparin complexes, the antibodies associated with the pathology of HIT.
› Verified 1 days ago
| Entity Name | Pioneer Hospitalists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033177316 PECOS PAC ID: 0941290290 Enrollment ID: O20040517001550 |
News Archive
New research reveals a Medicaid payment model in Oregon leads to fewer traditional primary care services for patients, with the decrease focused entirely on imaging.
Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.
Transitioning from a hospital visit can be challenge for many patients, but the homeless face particular difficulties as they move to a shelter, or even back to the streets. Researchers in this study surveyed 98 homeless individuals in New Haven, Conn., as well as interviewed them about their experiences leaving the hospital. More than half said that their providers did not address housing or transportation, and 11 percent reported living on the streets on the night of their discharge. The authors recommend "improved assessment of housing status, communication between hospital and shelter providers, and arrangement of safe transportation" for homeless individuals.
Instrumentation Laboratory (IL) today announced the release of the new HemosIL HIT-Ab(PF4-H) assay as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Delivering results in minutes, the HemosIL HIT-Ab(PF4-H) assay detects total immunoglobulin against Platelet Factor 4-Heparin complexes, the antibodies associated with the pathology of HIT.
› Verified 1 days ago
| Entity Name | Geriatric Specialties Of Arizona Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225023377 PECOS PAC ID: 9931189628 Enrollment ID: O20040722001190 |
News Archive
New research reveals a Medicaid payment model in Oregon leads to fewer traditional primary care services for patients, with the decrease focused entirely on imaging.
Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.
Transitioning from a hospital visit can be challenge for many patients, but the homeless face particular difficulties as they move to a shelter, or even back to the streets. Researchers in this study surveyed 98 homeless individuals in New Haven, Conn., as well as interviewed them about their experiences leaving the hospital. More than half said that their providers did not address housing or transportation, and 11 percent reported living on the streets on the night of their discharge. The authors recommend "improved assessment of housing status, communication between hospital and shelter providers, and arrangement of safe transportation" for homeless individuals.
Instrumentation Laboratory (IL) today announced the release of the new HemosIL HIT-Ab(PF4-H) assay as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Delivering results in minutes, the HemosIL HIT-Ab(PF4-H) assay detects total immunoglobulin against Platelet Factor 4-Heparin complexes, the antibodies associated with the pathology of HIT.
› Verified 1 days ago
| Entity Name | East Valley Diabetes & Endocrinology Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871887828 PECOS PAC ID: 1153593579 Enrollment ID: O20111007000205 |
News Archive
New research reveals a Medicaid payment model in Oregon leads to fewer traditional primary care services for patients, with the decrease focused entirely on imaging.
Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.
Transitioning from a hospital visit can be challenge for many patients, but the homeless face particular difficulties as they move to a shelter, or even back to the streets. Researchers in this study surveyed 98 homeless individuals in New Haven, Conn., as well as interviewed them about their experiences leaving the hospital. More than half said that their providers did not address housing or transportation, and 11 percent reported living on the streets on the night of their discharge. The authors recommend "improved assessment of housing status, communication between hospital and shelter providers, and arrangement of safe transportation" for homeless individuals.
Instrumentation Laboratory (IL) today announced the release of the new HemosIL HIT-Ab(PF4-H) assay as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Delivering results in minutes, the HemosIL HIT-Ab(PF4-H) assay detects total immunoglobulin against Platelet Factor 4-Heparin complexes, the antibodies associated with the pathology of HIT.
› Verified 1 days ago
| Entity Name | M S C Holding Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437437605 PECOS PAC ID: 2264608116 Enrollment ID: O20111227000784 |
News Archive
New research reveals a Medicaid payment model in Oregon leads to fewer traditional primary care services for patients, with the decrease focused entirely on imaging.
Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.
Transitioning from a hospital visit can be challenge for many patients, but the homeless face particular difficulties as they move to a shelter, or even back to the streets. Researchers in this study surveyed 98 homeless individuals in New Haven, Conn., as well as interviewed them about their experiences leaving the hospital. More than half said that their providers did not address housing or transportation, and 11 percent reported living on the streets on the night of their discharge. The authors recommend "improved assessment of housing status, communication between hospital and shelter providers, and arrangement of safe transportation" for homeless individuals.
Instrumentation Laboratory (IL) today announced the release of the new HemosIL HIT-Ab(PF4-H) assay as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Delivering results in minutes, the HemosIL HIT-Ab(PF4-H) assay detects total immunoglobulin against Platelet Factor 4-Heparin complexes, the antibodies associated with the pathology of HIT.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kristin L Hanson, MD 4100 S Lindsay Rd, Ste 130, Gilbert, AZ 85297-1508 Ph: (480) 782-9531 | Ms Kristin L Hanson, MD 4100 S Lindsay Rd, Ste 130, Gilbert, AZ 85297-1508 Ph: (480) 782-9531 |
News Archive
New research reveals a Medicaid payment model in Oregon leads to fewer traditional primary care services for patients, with the decrease focused entirely on imaging.
Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.
Transitioning from a hospital visit can be challenge for many patients, but the homeless face particular difficulties as they move to a shelter, or even back to the streets. Researchers in this study surveyed 98 homeless individuals in New Haven, Conn., as well as interviewed them about their experiences leaving the hospital. More than half said that their providers did not address housing or transportation, and 11 percent reported living on the streets on the night of their discharge. The authors recommend "improved assessment of housing status, communication between hospital and shelter providers, and arrangement of safe transportation" for homeless individuals.
Instrumentation Laboratory (IL) today announced the release of the new HemosIL HIT-Ab(PF4-H) assay as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Delivering results in minutes, the HemosIL HIT-Ab(PF4-H) assay detects total immunoglobulin against Platelet Factor 4-Heparin complexes, the antibodies associated with the pathology of HIT.
› Verified 1 days ago
Sandhyaben P Patel, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1900 N Higley Rd, Gilbert, AZ 85234 Phone: 480-543-2134 Fax: 480-512-6089 | |
Dr. Shivakumar Vignesh, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr., Suite 400, Gilbert, AZ 85234 Phone: 480-256-3332 Fax: 813-449-8028 | |
Dr. Noreen Catherine Ruane, D.O. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3555 S Val Vista Dr, Gilbert, AZ 85297 Phone: 602-933-0777 Fax: 602-933-0755 | |
Dr. Ala Eddin Samir Sagar, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2940 E Banner Gateway Drive, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 | |
Theresa Ong Liu Dumlao, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Suite 450, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-4683 | |
Dr. Zachary Phillip Yeung, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-245-6444 Fax: 480-256-4623 | |
Richard D Sue, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 |